0001125345-24-000055.txt : 20240306
0001125345-24-000055.hdr.sgml : 20240306
20240306161933
ACCESSION NUMBER: 0001125345-24-000055
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240304
FILED AS OF DATE: 20240306
DATE AS OF CHANGE: 20240306
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Spitznagel Thomas
CENTRAL INDEX KEY: 0001675464
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36112
FILM NUMBER: 24726137
MAIL ADDRESS:
STREET 1: 9704 MEDICAL CENTER DRIVE
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MACROGENICS INC
CENTRAL INDEX KEY: 0001125345
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9704 MEDICAL CENTER DRIVE
CITY: Rockville
STATE: MD
ZIP: 20850
BUSINESS PHONE: 301-251-5172
MAIL ADDRESS:
STREET 1: 9704 MEDICAL CENTER DRIVE
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
4
1
wk-form4_1709759960.xml
FORM 4
X0508
4
2024-03-04
0
0001125345
MACROGENICS INC
MGNX
0001675464
Spitznagel Thomas
9704 MEDICAL CENTER DRIVE
ROCKVILLE
MD
20850
0
1
0
0
Sr VP, Technical Ops
1
Common Stock
2024-03-04
4
M
0
10000
11.50
A
18316
D
Common Stock
2024-03-04
4
S
0
10000
20
D
8316
D
Employee stock option (right to buy)
11.50
2024-03-04
4
M
0
10000
0
D
2030-02-20
Common Stock
10000
77000
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/17/2023.
12.5% of the shares underlying the grant became exercisable 6 months after the date of grant and an additional 6.25% of the shares underlying the grant became exercisable on the first day of each three-month period thereafter.
/s/ Lynn M. Cilinski, Attorney-in-fact
2024-03-06